MENU
XLO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xilio Therapeutics (XLO) Ownership - Who owns Xilio Therapeutics?
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments... Show more
Profile
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
35.34M
P/E Ratio
N/A
Total Cash
89.07M
Projected Growth
N/A
Total Debt
7.86M
Revenue
9.27M
Risk (Beta)
-0.63
Dividend Yield
N/A
Total Cash/Share
1.72
Total Debt/Equity
N/A
Revenue/Share
0.14 USD as % of share price
Fundamentals
XLO
Capitalization
35.3M
P/E Ratio
N/A
Risk (Beta)
-0.63
Dividend Yield
N/A
Total Cash
89.1M
Total Cash/Share
1.72
Total Debt
7.86M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.14%
Revenue
9.27M
ROE
N/A
Book Value
10.7M
P/B Ratio
3.30
Cash Flow
N/A
Earnings
-0.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
1.96
Current Revenue Per Employee
40136.98
Dividends Per Share - Security
N/A
EBITDA
-55.26M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-58.29
Shares Held By Institutions
10.9M
Shares Outstanding - Current
51.8M
Total Liabilities
93M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-28.545
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
828 Winter Street
Phone
+1 857 524-2466
Employees
73
Web
https://www.xiliotx.com